The immune-brain loop: a world where more and more clinicians boldly go—and thrive—among new discoveries.
The neuroprotective role of resilience in patients with schizophrenia who experienced early childhood trauma is evaluated in this brief update.
This month's roundup features noteworthy stories from around the web: the humanitarian crisis at the border, new gaming disorder diagnosis, a medication investigation of over 26,000 adult patients, a boundary-busting neurologist, and physician and celebrity suicides.
Revival of an old drug, declaration of independence for seniors, inmates doing more than time—these and other stories are covered in our monthly roundup.
For the first time, a study has shown comprehensive evidence for the effect of depression on decline in overall cognitive function. Plus, 2 more findings.
Negative symptoms identified from the Negative Symptom Assessment and the behaviors that might be observed in each of 5 domains.
Three new studies examine research on biomarkers to predict lifetime risk of Alzheimer disease; diet and brain tissue volume; and cognitive impairment in active older adults.
A rare but serious reaction to this treatment can have immunological consequences. As with all medications, however, the latest alert does not change how psychiatrists manage the risks.
The Department of Justice apprehended a perpetrator whose electronic stalking behaviors went to the extreme. This and other editors’ choices on stories you may have missed.
Three new studies highlight sedentary behavior and memory, cognitive decline in psychosis, and risk of dementia with anticholinergic drugs.